657 related articles for article (PubMed ID: 30031930)
1. Early minor stimulation of microglial TLR2 and TLR4 receptors attenuates Alzheimer's disease-related cognitive deficit in rats: behavioral, molecular, and electrophysiological evidence.
Pourbadie HG; Sayyah M; Khoshkholgh-Sima B; Choopani S; Nategh M; Motamedi F; Shokrgozar MA
Neurobiol Aging; 2018 Oct; 70():203-216. PubMed ID: 30031930
[TBL] [Abstract][Full Text] [Related]
2. Prestimulation of Microglia Through TLR4 Pathway Promotes Interferon Beta Expression in a Rat Model of Alzheimer's Disease.
Yousefi N; Sotoodehnejadnematalahi F; Heshmati-Fakhr N; Sayyah M; Hoseini M; Ghassemi S; Aliakbari S; Pourbadie HG
J Mol Neurosci; 2019 Apr; 67(4):495-503. PubMed ID: 30610591
[TBL] [Abstract][Full Text] [Related]
3. Hypoxic-conditioned medium from adipose tissue mesenchymal stem cells improved neuroinflammation through alternation of toll like receptor (TLR) 2 and TLR4 expression in model of Alzheimer's disease rats.
Mehrabadi S; Motevaseli E; Sadr SS; Moradbeygi K
Behav Brain Res; 2020 Feb; 379():112362. PubMed ID: 31739000
[TBL] [Abstract][Full Text] [Related]
4. Triggering microglia through toll-like receptor 2 pathway induced interferon β expression in cell and animal model of Alzheimer's disease.
Heshmati-Fakhr N; Sotoodehnejadnematalahi F; Yousefi N; Sayyah M; Hosseini SM; Pourbadie HG
Neuroreport; 2018 Dec; 29(17):1456-1462. PubMed ID: 30222725
[TBL] [Abstract][Full Text] [Related]
5. TLR4 mutation reduces microglial activation, increases Aβ deposits and exacerbates cognitive deficits in a mouse model of Alzheimer's disease.
Song M; Jin J; Lim JE; Kou J; Pattanayak A; Rehman JA; Kim HD; Tahara K; Lalonde R; Fukuchi K
J Neuroinflammation; 2011 Aug; 8():92. PubMed ID: 21827663
[TBL] [Abstract][Full Text] [Related]
6. Fibrillar amyloid-beta peptides activate microglia via TLR2: implications for Alzheimer's disease.
Jana M; Palencia CA; Pahan K
J Immunol; 2008 Nov; 181(10):7254-62. PubMed ID: 18981147
[TBL] [Abstract][Full Text] [Related]
7. Inhibiting TLR2 activation attenuates amyloid accumulation and glial activation in a mouse model of Alzheimer's disease.
McDonald CL; Hennessy E; Rubio-Araiz A; Keogh B; McCormack W; McGuirk P; Reilly M; Lynch MA
Brain Behav Immun; 2016 Nov; 58():191-200. PubMed ID: 27422717
[TBL] [Abstract][Full Text] [Related]
8. Role of toll-like receptor signalling in Abeta uptake and clearance.
Tahara K; Kim HD; Jin JJ; Maxwell JA; Li L; Fukuchi K
Brain; 2006 Nov; 129(Pt 11):3006-19. PubMed ID: 16984903
[TBL] [Abstract][Full Text] [Related]
9. Thymoquinone alleviates the experimentally induced Alzheimer's disease inflammation by modulation of TLRs signaling.
Abulfadl YS; El-Maraghy NN; Ahmed AE; Nofal S; Abdel-Mottaleb Y; Badary OA
Hum Exp Toxicol; 2018 Oct; 37(10):1092-1104. PubMed ID: 29405769
[TBL] [Abstract][Full Text] [Related]
10. Monophosphoryl Lipid-A: A Promising Tool for Alzheimer's Disease Toll.
Rego Â; Viana SD; Ribeiro CA; Rodrigues-Santos P; Pereira FC
J Alzheimers Dis; 2016 Apr; 52(4):1189-202. PubMed ID: 27079716
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor 4-dependent upregulation of cytokines in a transgenic mouse model of Alzheimer's disease.
Jin JJ; Kim HD; Maxwell JA; Li L; Fukuchi K
J Neuroinflammation; 2008 May; 5():23. PubMed ID: 18510752
[TBL] [Abstract][Full Text] [Related]
12. α-TLR2 antibody attenuates the Aβ-mediated inflammatory response in microglia through enhanced expression of SIGIRR.
Costello DA; Carney DG; Lynch MA
Brain Behav Immun; 2015 May; 46():70-9. PubMed ID: 25620736
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor 4 stimulation with the detoxified ligand monophosphoryl lipid A improves Alzheimer's disease-related pathology.
Michaud JP; Hallé M; Lampron A; Thériault P; Préfontaine P; Filali M; Tribout-Jover P; Lanteigne AM; Jodoin R; Cluff C; Brichard V; Palmantier R; Pilorget A; Larocque D; Rivest S
Proc Natl Acad Sci U S A; 2013 Jan; 110(5):1941-6. PubMed ID: 23322736
[TBL] [Abstract][Full Text] [Related]
14. Low-Dose Ionizing Radiation Modulates Microglia Phenotypes in the Models of Alzheimer's Disease.
Kim S; Chung H; Ngoc Mai H; Nam Y; Shin SJ; Park YH; Chung MJ; Lee JK; Rhee HY; Jahng GH; Kim Y; Lim YJ; Kong M; Moon M; Chung WK
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630597
[TBL] [Abstract][Full Text] [Related]
15. Cooperative therapeutic action of retinoic acid receptor and retinoid x receptor agonists in a mouse model of Alzheimer's disease.
Kawahara K; Suenobu M; Ohtsuka H; Kuniyasu A; Sugimoto Y; Nakagomi M; Fukasawa H; Shudo K; Nakayama H
J Alzheimers Dis; 2014; 42(2):587-605. PubMed ID: 24916544
[TBL] [Abstract][Full Text] [Related]
16. Microglial Aβ receptors in Alzheimer's disease.
Yu Y; Ye RD
Cell Mol Neurobiol; 2015 Jan; 35(1):71-83. PubMed ID: 25149075
[TBL] [Abstract][Full Text] [Related]
17. Highly purified lipoteichoic acid induced pro-inflammatory signalling in primary culture of rat microglia through Toll-like receptor 2: selective potentiation of nitric oxide production by muramyl dipeptide.
Kinsner A; Boveri M; Hareng L; Brown GC; Coecke S; Hartung T; Bal-Price A
J Neurochem; 2006 Oct; 99(2):596-607. PubMed ID: 16879708
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol mitigates lipopolysaccharide- and Aβ-mediated microglial inflammation by inhibiting the TLR4/NF-κB/STAT signaling cascade.
Capiralla H; Vingtdeux V; Zhao H; Sankowski R; Al-Abed Y; Davies P; Marambaud P
J Neurochem; 2012 Feb; 120(3):461-72. PubMed ID: 22118570
[TBL] [Abstract][Full Text] [Related]
19. Microglial response to LPS increases in wild-type mice during aging but diminishes in an Alzheimer's mouse model: Implication of TLR4 signaling in disease progression.
Go M; Kou J; Lim JE; Yang J; Fukuchi KI
Biochem Biophys Res Commun; 2016 Oct; 479(2):331-337. PubMed ID: 27641666
[TBL] [Abstract][Full Text] [Related]
20. Preconditioning with toll-like receptor agonists attenuates seizure activity and neuronal hyperexcitability in the pilocarpine rat model of epilepsy.
Hosseinzadeh M; Pourbadie HG; Khodagholi F; Daftari M; Naderi N; Motamedi F
Neuroscience; 2019 Jun; 408():388-399. PubMed ID: 31026566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
